MoneyWorks4Me

The sales is pegged at Rs. 225.75 millions for the March 2025 quarter. The mentioned figure indicates a decline of about -37.96% as against Rs. 363.86 millions during the year-ago period.The Net Loss for the quarter ended March 2025 is Rs. -44.17 millions as compared to Net Profit of Rs. 55.13 millions of corresponding quarter ended March 2024 Operating profit Margin for the quarter ended March 2025 improved to 16.71% as compared to -214.55% of corresponding quarter ended March 2024


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 225.75 363.86 -37.96 1036.04 1367.97 -24.26 1036.04 1367.97 -24.26
Other Income 41.52 73.69 -43.66 41.85 95.72 -56.28 41.85 95.72 -56.28
PBIDT 16.71 -214.55 -107.79 -103.34 -240.68 -57.06 -103.34 -240.68 -57.06
Interest 14.76 -336.91 -104.38 25.31 19.04 32.93 25.31 19.04 32.93
PBDT 1.95 122.36 -98.41 -128.65 -259.72 -50.47 -128.65 -259.72 -50.47
Depreciation 46.12 49.55 -6.92 186.31 184.10 1.20 186.31 184.10 1.20
PBT -44.17 72.81 -160.66 -314.96 -443.82 -29.03 -314.96 -443.82 -29.03
TAX 0.00 17.68 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 17.68 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -44.17 55.13 -180.12 -314.96 -443.82 -29.03 -314.96 -443.82 -29.03
Equity 165.83 165.83 0.00 165.83 165.83 0.00 165.83 165.83 0.00
PBIDTM(%) 7.40 -58.96 -112.55 -9.97 -17.59 -43.31 -9.97 -17.59 -43.31
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..